LIST OF TABLES

TABLE 01.ANTIGEN-BASED TEST KIT AND MANUFACTURERS
TABLE 02.APPROVED COVID-19 DIAGNOSTIC PRODUCTS
TABLE 03.COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 04.COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 05.COVID-19 DIAGNOSTICS MARKET,BY TECHNOLOGY, 2022 ($MILLION)
TABLE 06.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2020 ($MILLION)
TABLE 07.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2021 ($MILLION)
TABLE 08.COVID-19 DIAGNOSTICS MARKET FOR MOLECULAR ASSAY, BY REGION, 2022 ($MILLION)
TABLE 09.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2020 ($MILLION)
TABLE 10.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2021 ($MILLION)
TABLE 11.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2022 ($MILLION)
TABLE 12.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 13.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 14.COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 15.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2020 ($MILLION)
TABLE 16.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2021 ($MILLION)
TABLE 17.COVID-19 DIAGNOSTICS MARKET, FOR PCR KITS, BY REGION, 2022 ($MILLION)
TABLE 18.COVID-19 DIAGNOSTICS MARKET FOR IMMUNOASSAY TEST, BY REGION, 2020 ($MILLION)
TABLE 19.COVID-19 DIAGNOSTICS MARKET, FOR IMMUNOASSAY TEST, BY REGION, 2021 ($MILLION)
TABLE 20.COVID-19 DIAGNOSTICS MARKET, FOR IMMUNOASSAY TEST, BY REGION, 2022 ($MILLION)
TABLE 21.COVID-19 DIAGNOSTICS MARKET FOR POC TEST KITS, BY REGION, 2020 ($MILLION)
TABLE 22.COVID-19 DIAGNOSTICS MARKET, FOR POC TEST KITS, BY REGION, 2021 ($MILLION)
TABLE 23.COVID-19 DIAGNOSTICS MARKET, FOR POC TEST KITS, BY REGION, 2022 ($MILLION)
TABLE 24.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 25.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 26.COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 27.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2020 ($MILLION)
TABLE 28.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2021 ($MILLION)
TABLE 29.COVID-19 DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2022 ($MILLION)
TABLE 30.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020 ($MILLION)
TABLE 31.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021 ($MILLION)
TABLE 32.COVID-19 DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022 ($MILLION)
TABLE 33.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2020 ($MILLION)
TABLE 34.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2021 ($MILLION)
TABLE 35.COVID-19 DIAGNOSTICS MARKET, FOR PHYSICIAN OFFICES & URGENT CARE CLINICS, BY REGION, 2022 ($MILLION)
TABLE 36.COVID-19 DIAGNOSTICS MARKET, BY REGION, 2020-2022 ($MILLION)
TABLE 37.COVID-19 DIAGNOSTICS MARKET, BY REGION, 2020-2022 (NUMBER OF TESTS)
TABLE 38.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 39.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 40.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 41.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 42.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 43.NORTH AMERICA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 (NUMBER OF TESTS)
TABLE 44.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 45.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 46.U.S. COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 47.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 48.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 49.U.S. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 50.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 51.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 52.U.S. COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 53.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 54.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 55.CANADA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 56.CANADA. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 57.CANADA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 58.CANADA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 59.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 60.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 61.CANADA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 62.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 63.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 64.MEXICO COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 65.MEXICO. COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 66.MEXICO COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 67.MEXICO COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 68.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 69.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 70.MEXICO COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 71.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 72.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 73.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 74.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 75.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 76.EUROPE COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 77.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 78.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 79.FRANCE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 80.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 81.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 82.FRANCE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 83.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 84.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 85.FRANCE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 86.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 87.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 88.UK COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 89.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 90.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 91.UK COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 92.UK COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 93.UK COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 94.UK DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 95.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 96.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 97.GERMANY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 98.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 99.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 100.GERMANY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 101.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 102.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 103.GERMANY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 104.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 105.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 106.SPAIN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 107.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 108.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 109.SPAIN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 110.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 111.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 112.SPAIN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 113.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 114.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 115.ITALY COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 116.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 117.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 118.ITALY COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 119.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 120.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 121.ITALY COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 122.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 123.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 124.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 125.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 126.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 127.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 128.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 129.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 130.AUSTRIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 131.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 132.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 133.ESTONIACOVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 134.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 135.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 136.ESTONIACOVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 137.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 138.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 139.ESTONIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 140.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 141.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 142.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 143.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 144.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 145.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 146.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 147.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 148.CZECH REPUBLIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 149.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 150.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 151.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 152.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 153.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 154.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 155.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 156.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 157.REST OF EUROPE COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 158.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020($MILLION)
TABLE 159.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 (NUMBER OF TESTS)
TABLE 160.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021($MILLION)
TABLE 161.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 (NUMBER OF TESTS)
TABLE 162.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022($MILLION)
TABLE 163.ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 (NUMBER OF TESTS)
TABLE 164.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 165.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 166.JAPAN COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 167.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 168.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 169.JAPAN COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 170.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 171.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 172.JAPAN COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 173.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 174.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 175.CHINA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 176.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 177.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 178.CHINA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 179.CHINA DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 180.CHINA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 181.CHINA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 182.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 183.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 184.INDIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 185.INDIACOVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 186.INDIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 187.INDIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 188.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 189.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 190.INDIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 191.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 192.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 193.AUSTRALIA MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 194.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 195.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 196.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 197.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 198.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 199.AUSTRALIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 200.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 201.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 202.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 203.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 204.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 205.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 206.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 207.SOUTH KOREACOVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 208.SOUTH KOREA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 209.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 210.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 211.THAILAND COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 212.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 213.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 214.THAILAND COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 215.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 216.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 217.THAILAND COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 218.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 219.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 220.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 221.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 222.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 223.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 224.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 225.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 226.MALAYSIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 227.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 228.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 229.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 230.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 231.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 232.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 233.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 234.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 235.REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 236.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020 ($MILLION)
TABLE 237.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2020(NUMBER OF TESTS)
TABLE 238.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021 ($MILLION)
TABLE 239.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2021(NUMBER OF TESTS)
TABLE 240.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022 ($MILLION)
TABLE 241.LAMEA COVID-19 DIAGNOSTICS MARKET, BY COUNTRY, 2022(NUMBER OF TESTS)
TABLE 242.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 243.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 244.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 245.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 246.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 247.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 248.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 249.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 250.BRAZIL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 251.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 252.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 253.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 254.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 255.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 256.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 257.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 258.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 259.SOUTH AFRICA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 260.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 261.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 262.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 263.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 264.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 265.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 266.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 267.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 268.SAUDI ARABIA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 269.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 270.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 271.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 272.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 273.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 274.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 275.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 276.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 277.ISRAEL COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 278.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 ($MILLION)
TABLE 279.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 ($MILLION)
TABLE 280.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 ($MILLION)
TABLE 281.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2020 ($MILLION)
TABLE 282.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2021 ($MILLION)
TABLE 283.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY PRODUCT, 2022 ($MILLION)
TABLE 284.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2020 ($MILLION)
TABLE 285.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2021 ($MILLION)
TABLE 286.REST OF LAMEA COVID-19 DIAGNOSTICS MARKET, BY END USER, 2022 ($MILLION)
TABLE 287.ABBOTT: COMPANY SNAPSHOT
TABLE 288.ABBOTT: OERATING SEGMENT
TABLE 289.ABBOTT: PRODUCT PORTFOLIO
TABLE 290.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 291.CELLEX: COMPANY SNAPSHOT
TABLE 292.CELLEX: OPERATING SEGMENTS
TABLE 293.CELLEX: PRODUCT PORTFOLIO
TABLE 294.CELLEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 295.CEPHEID: COMPANY SNAPSHOT
TABLE 296.CEPHEID: OPERATING BUSINESS SEGMENTS
TABLE 297.CEPHEID: PRODUCT PORTFOLIO
TABLE 298.ROCHE: COMPANY SNAPSHOT
TABLE 299.ROCHE: OPERATING SEGMENTS
TABLE 300.ROCHE: PRODUCT PORTFOLIO
TABLE 301.HOLOGIC: COMPANY SNAPSHOT
TABLE 302.HOLOGIC: OPERATING BUSINESS SEGMENTS
TABLE 303.HOLOGIC: PRODUCT PORTFOLIO
TABLE 304.LABCORP: COMPANY SNAPSHOT
TABLE 305.LABCORP: OPERATING SEGMENTS
TABLE 306.LABCORP: PRODUCT PORTFOLIO
TABLE 307.MYLAB: COMPANY SNAPSHOT
TABLE 308.MYLAB: PRODUCT SEGMENTS
TABLE 309.MYLAB: PRODUCT PORTFOLIO
TABLE 310.QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 311.QUEST DIAGNOSTICS: OPERATING BUSINESS SEGMENTS
TABLE 312.QUEST: PRODUCT PORTFOLIO
TABLE 313.SEEGENE: COMPANY SNAPSHOT
TABLE 314.SEEGENE: OPERATING SEGMENTS
TABLE 315.SEEGENE: PRODUCT PORTFOLIO
TABLE 316.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 317.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 318.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01.COVID-19 DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 03.LOW BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE THREAT OF SUBSTITUTES
FIGURE 05.LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.HIGH COMPETITIVE RIVALARY
FIGURE 07.DRIVERS AND RESTRAINTS
FIGURE 08.MARKET SHARE ANALYSIS, MOLECULAR KITS
FIGURE 09.MARKET SHARE ANALYSIS, IMMUNOASSAY TEST
FIGURE 10.MARKET SHARE ANALYSIS, MOLECULAR POINT OF CARE KITS
FIGURE 11.MARKET SHARE ANALYSIS, NORTH AMERICA MOLECULAR KITS
FIGURE 12.MARKET SHARE ANALYSIS, NORTH AMERICA IMMUNOASSAY TEST
FIGURE 13.MARKET SHARE ANALYSIS, NORTH AMERICA MOLECULAR POINT OF CARE KITS
FIGURE 14.MARKET SHARE ANALYSIS, EUROPE MOLECULAR KITS
FIGURE 15.MARKET SHARE ANALYSIS, EUROPE IMMUNOASSAY TEST
FIGURE 16.MARKET SHARE ANALYSIS, EUROPE MOLECULAR POINT OF CARE KITS
FIGURE 17.MARKET SHARE ANALYSIS, ASIA-PACIFIC MOLECULAR KITS (RT PCR)
FIGURE 18.MARKET SHARE ANALYSIS, ASIA-PACIFIC IMMUNOASSAY TEST
FIGURE 19.MARKET SHARE ANALYSIS, ASIA-PACIFIC MOLECULAR POINT OF CARE KITS
FIGURE 20.MARKET SHARE ANALYSIS, LAMEA MOLECULAR KITS
FIGURE 21.MARKET SHARE ANALYSIS, LAMEA IMMUNOASSAY TEST
FIGURE 22.MARKET SHARE ANALYSIS, LAMEA MOLECULAR POINT OF CARE KITS
FIGURE 23.ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 24.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 25.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 26.ROCHE: NET SALES, 2017-2019 ($MILLION)
FIGURE 27.ROCHE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 28.ROCHE: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 29.HOLOGIC: NET SALES, 2017-2019 ($MILLION)
FIGURE 30.HOLOGIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.HOLOGIC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 32.LABCORP: NET SALES, 2017-2019 ($MILLION)
FIGURE 33.LABCORP: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.LABCORP: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.QUEST DIAGNOSTICS: NET SALES, 2017-2019 ($MILLION)
FIGURE 36.QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 37.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017-2019 ($MILLION)
FIGURE 38.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 39.THERMO FISHER SCIENTIFIC. REVENUE SHARE BY REGION, 2019 (%)